Recent advances in imaging-guided interventions for prostate cancers.

Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers. Cancer Nanotechnol (2016) 0.75

Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38

Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74

Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol (2011) 4.99

The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol (2002) 4.14

Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol (1989) 3.78

Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol (2011) 3.19

Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. Radiology (2010) 3.12

Design of a novel MRI compatible manipulator for image guided prostate interventions. IEEE Trans Biomed Eng (2005) 3.08

Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study. J Natl Cancer Inst (2010) 2.45

Advancements in MR imaging of the prostate: from diagnosis to interventions. Radiographics (2011) 2.17

Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy. Prostate (2008) 2.16

Diffusion-weighted magnetic resonance imaging in patients with unilateral prostate cancer on extended prostate biopsy: predictive accuracy of laterality and implications for hemi-ablative therapy. J Urol (2010) 2.09

Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. Eur Urol (2006) 2.00

Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. J Magn Reson Imaging (2010) 1.87

Image guided photothermal focal therapy for localized prostate cancer: phase I trial. J Urol (2009) 1.84

Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur Urol (2007) 1.82

Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding--multiparametric MR imaging for detection and biopsy planning. Radiology (2011) 1.69

Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol (1983) 1.67

Optimising repeat prostate biopsy decisions and procedures. BJU Int (2011) 1.62

Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer. Eur Urol (2010) 1.57

Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology (2009) 1.55

Magnetic nanoparticles for interstitial thermotherapy--feasibility, tolerance and achieved temperatures. Int J Hyperthermia (2006) 1.50

Magnetic nanoparticle hyperthermia for prostate cancer. Int J Hyperthermia (2010) 1.50

Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial. Int J Hyperthermia (2007) 1.48

Renal tumors: MR imaging-guided percutaneous cryotherapy--initial experience in 23 patients. Radiology (2005) 1.45

MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy. World J Urol (2011) 1.32

Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response. J Urol (2007) 1.30

Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy. Eur Urol (2010) 1.25

Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses. BJU Int (2008) 1.23

Imaging-guided prostate biopsy: conventional and emerging techniques. Radiographics (2012) 1.23

Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts. Int J Cancer (2003) 1.19

Thermal monitoring: invasive, minimal-invasive and non-invasive approaches. Int J Hyperthermia (2006) 1.18

Value of real-time elastography targeted biopsy for prostate cancer detection in men with prostate specific antigen 1.25 ng/ml or greater and 4.00 ng/ml or less. J Urol (2010) 1.07

Analysis of the spatial and temporal accuracy of heating in the prostate gland using transurethral ultrasound therapy and active MR temperature feedback. Phys Med Biol (2009) 1.07

MRI-guided prostate brachytherapy with single needle method--a planning study. Radiother Oncol (2004) 1.06

Current status of HIFU and cryotherapy in prostate cancer--a review. Eur Urol (2006) 1.06

Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy. Cancer (2009) 1.02

Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: implications for focal therapy. J Urol (2012) 1.01

A novel MRI marker for prostate brachytherapy. Int J Radiat Oncol Biol Phys (2008) 0.99

Photodynamic therapy of localised prostatic cancer. Lancet (1990) 0.93

3.0T MR-guided laser ablation of a prostate cancer recurrence in the postsurgical prostate bed. J Vasc Interv Radiol (2011) 0.93

Technical developments for cerebral thermal treatment: water-cooled diffusing laser fibre tips and temperature-sensitive MRI using intersecting image planes. Int J Hyperthermia (2004) 0.93

Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection. Eur Radiol (2010) 0.92

Feasibility of 3.0T magnetic resonance imaging-guided laser ablation of a cadaveric prostate. Urology (2010) 0.90

Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer. Urology (2008) 0.89

Percutaneous MR-guided cryoablation of prostate cancer: initial experience. Eur Radiol (2012) 0.88

[Detection of prostate cancer by real-time MR/ultrasound fusion-guided biopsy: 3T MRI and state of the art sonography]. Rofo (2013) 0.87

Vascular targeted photodynamic therapy for localized prostate cancer. Rev Urol (2008) 0.85

Evaluation of the photosensitizer Tookad for photodynamic therapy on the Syrian golden hamster cheek pouch model: light dose, drug dose and drug-light interval effects. Photochem Photobiol (2003) 0.85

PEGylation of liposome decreases the susceptibility of liposomal drug in cancer photodynamic therapy. Biol Pharm Bull (2004) 0.84

Indications and timing for prostate biopsy, diagnosis of early stage prostate cancer and its definitive treatment: a clinical conundrum in the PSA era. Surg Oncol (2009) 0.84

Image guidance for focal therapy of prostate cancer. World J Urol (2010) 0.83

Contemporary results of focal therapy for prostate cancer using cryoablation. J Endourol (2010) 0.81

Cryosurgery as primary treatment for localized prostate cancer. Int Urol Nephrol (2011) 0.81

Biophysiologic considerations in cryoablation: a practical mechanistic molecular review. Int Braz J Urol (2012) 0.81

Magnetic resonance imaging and model prediction for thermal ablation of tissue. J Magn Reson Imaging (2007) 0.78

Robotic prostate biopsy and its relevance to focal therapy of prostate cancer. Nat Rev Urol (2011) 0.77

Endoscopic cryosurgery of prostate and bladder tumors. J Urol (1972) 0.77

Indications for extended 14-core transrectal ultrasound-guided prostate biopsy. Urology (2008) 0.76